TMCnet News
Good Start Genetics, IviGen and iGenomix Announce Exclusive Relationship in Reproductive TestingGood Start Genetics®, Inc., a commercial-stage molecular genetic information company, IviGen LLC®, and its parent company iGenomix®, providers of advanced services in reproductive genetics, today announced an exclusive relationship to bring a breadth of advanced offerings in reproductive genetics to the reproductive health community. The relationship brings together a suite of leading products for in vitro fertilization (IVF) specialists and the broader women's health community, including obstetrics and gynecology (OBGYN) and maternal fetal medicine (MFM) physicians, across the US and Canada. The agreement also lays the foundation for future collaboration in the development and global distribution of additional advanced reproductive health products. "Our relationship with IviGen and iGenomix, and the addition of their leading, genetics-based reproductive products, represents a transformative step in establishing Good Start as a comprehensive, reproductive health company, serving the needs of a broad range of IVF, MFM and OBGYN physicians," stated Don Hardison, president and chief executive officer of Good Start Genetics. "IviGen has rigorously developed a set of high-quality, state of the art technologies already in use by leading IVF centers across the U.S. We are honored to be working with IviGen and iGenomix, and look forward to a long, productive and prosperous relationship." The relationship complements Good Start's premier carrier screening offering, GoodStart Select™, with the following advanced, genetics-based reproductive health products developed by IviGen and iGenomix to manage many of the challenges of infertility:
About GoodStart Select™ GoodStart Select is Good Start Genetics' menu of genetic carrier screening tests that, for diseases such as cystic fibrosis, detects many more disease-causing mutations than traditional genotyping- based screening tests, regardless of patient ethnicity. The product of years of development and rigorous validation, GoodStart Select includes a suite of proprietary technologies, processes and algorithms designed to harness the power of next-generation DNA sequencing (NGS), to provide highly accurate and actionable tests resulting in higher mutation detection rates and fewer missed carriers. To support its genetic carrier screening capabilities, Good Start Genetics has a dedicated team of customer care specialists and board certified genetic counselors who provide step-by-step support, from test selection through results, analysis and reporting. Good Start Genetics seeks to enable reproductive health specialists and their patients to have the highest degree of confidence in their genetic carrier screening results. About Good Start Genetics, Inc. Good Start Genetics is a commercial-stage molecular genetic information company focused on fundamentally transforming the standard of care in reproductive medicine by providing physicians and their patients with clinically relevant and actionable information concerning inherited genetic disorders. Good Start Genetics' powerful, proprietary next-generation DNA sequencing (NGS) capabilities are supplemented by other proven genetic screening technologies and supported by its commitment to customer care and genetic counseling. Through GoodStart Select, the company provides a comprehensive and clinically actionable menu of genetic carrier screening tests for known and novel mutations that cause inherited genetic disorders. For more information, please visit www.goodstartgenetics.com. About IviGen IviGen provides advanced genetic diagnostic services to help couples build healthy families. IviGen's goal is patient and clinic satisfaction. The company provides superior genetic services that help to improve clinical results: PGS, PGD, ERA®, POC and Sperm Aneuploidy Test. IviGen is the affiliate of iGenomix in the US. For more information, please visit www.ivigen.com. About iGenomix iGenomix has broad experience in genetic and molecular diagnosis and is one of the world's leaders in these techniques with affiliates and labs in Brazil, USA, Spain, United Arab Emirates and India. Igenomix's efforts in R&D enable the company to create and develop specific proprietary tools to support professionals in the reproductive medicine field. iGenomix offers services such as PGS, PGD, ERA®, POC, CGT (Compatibility Genetic Test) and NACE (Non-Invasive Chromosomal Examination). For more information, please visit www.igenomix.com. 1 At ISI (News - Alert) Web of Knowledge (http://apps.isiknowledge.com) iGenomix, through Prof. Carlos Simón, is author of 367 publications with an accumulated impact factor of 1,592.265, all publications add up a total of 11,966 cites with an average of 32.60 citations/publications.
|